Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations

Jaesung P. Choi(The University of Sydney), Xiangjian Zheng(Tianjin Medical University)
Science Advances
November 2, 2018
Cited by 52


Related Papers